GORE® CARDIOFORM Septal Occluder and Antiplatelet medical management for reduction of recurrent stroke in patients with Patent Foremen Ovale (PFO): The REDUCE post approval study,
Role: PI,
W.L. Gore & Associates, Inc.,
(06/2024 - 06/2025)
Status: Approved
A Prospective, Multi-Center, Randomized, Controlled, Single Blind Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class Ill Heart Failure Patients (PROACTIVE- HF Trial),
Role: Investigator,
Endotronix, Inc.,
(01/2025 - 01/2026)
Status: Approved
National cardiogenic shock initiative,
Role: Investigator,
LLU Dept. of Cardiology,
(07/2020 - 07/2021)
Status: Completed
A Retrospective Analysis and Review of Patients Undergoing Impella, a Temporary Left Ventricular Support Device, Implantation for Complex Coronary Intervention or Cardiogenic Shock,
Role: Investigator,
LLU Dept. of Medicine,
(04/2020)
Status: Approved
Non-Profit Organization
Cardiovascular inflammation reduction trial (CIRT): a randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose Methotrexate(LDM) in the prevention of cardiovascular events among stable coronary artery disease patients with type 2 diabetes or metabolic syndrome,
Role: Investigator,
Brigham & Women's Hospital,
(08/2017 - 08/2018)
Status: Completed